| Date | Time | Source | Announcement |
|---|---|---|---|
| 09 Feb 2006 | 07:00 AM | Transaction in Own Shares | |
| 06 Feb 2006 | 07:00 AM | Transaction in Own Shares | |
| 03 Feb 2006 | 07:00 AM | Transaction in Own Shares | |
| 02 Feb 2006 | 11:00 AM | Final Results - Part 3 of 3 | |
| 02 Feb 2006 | 11:00 AM | Final Results - Part 2 of 3 | |
| 02 Feb 2006 | 11:00 AM | Final Results - Part 1 of 3 | |
| 01 Feb 2006 | 09:00 AM | Notice of Results | |
| 24 Jan 2006 | 04:00 PM | Director/PDMR Shareholding | |
| 18 Jan 2006 | 08:24 AM | Toprol-XL | |
| 03 Jan 2006 | 07:06 AM | Seroquel | |
| 28 Dec 2005 | 07:00 AM | Collaboration Agreement | |
| 23 Dec 2005 | 07:00 AM | KuDOS Pharmaceuticals | |
| 22 Dec 2005 | 02:40 PM | Collaboration | |
| 20 Dec 2005 | 04:00 PM | Holding(s) in Company | |
| 16 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 15 Dec 2005 | 12:00 PM | Director/PDMR Shareholding | |
| 15 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 14 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 09 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 08 Dec 2005 | 07:01 AM | Licensing Agreement | |
| 08 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 07 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 02 Dec 2005 | 04:00 PM | Director/PDMR Shareholding | |
| 02 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 01 Dec 2005 | 07:00 AM | Transaction in Own Shares | |
| 30 Nov 2005 | 04:00 PM | Holding(s) in Company | |
| 29 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 24 Nov 2005 | 04:00 PM | Holding(s) in Company | |
| 24 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 23 Nov 2005 | 04:00 PM | Holding(s) in Company | |
| 22 Nov 2005 | 07:01 AM | Nexium | |
| 22 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 21 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 18 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 17 Nov 2005 | 04:00 PM | Holding(s) in Company | |
| 17 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 16 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 15 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 14 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 11 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 10 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 09 Nov 2005 | 07:00 AM | Seroquel | |
| 07 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 04 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 03 Nov 2005 | 07:00 AM | Transaction in Own Shares | |
| 01 Nov 2005 | 04:30 PM | Holding(s) in Company | |
| 31 Oct 2005 | 01:30 PM | Zactima | |
| 31 Oct 2005 | 07:00 AM | Transaction in Own Shares | |
| 28 Oct 2005 | 04:00 PM | Holding(s) in Company | |
| 27 Oct 2005 | 11:00 AM | 3rd Quarter Results (2 of 2) |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.